Status
Conditions
Treatments
About
This is an observational study that will include both participants with relapsed/refractory Multiple Myeloma and their doctors. The purpose of this study is to gather information about the use of hematopoietic cell transplantation/HCT and B-cell maturation antigen /BCMS targeted chimeric antigen receptor/CAR autologous T-cell therapy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patient
Physician Investigator
Exclusion criteria
Patient
400 participants in 5 patient groups
Loading...
Central trial contact
Carlyn Tan, MD; Heather Landau, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal